Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Conditions
- Age-related Wet Macular Degeneration
Interventions
- DRUG: CG-P5 peptide
- DRUG: Placebo
- DRUG: Aflibercept Injection [Eylea]
Sponsor
Caregen Co. Ltd.
Collaborators